KEY FEATURES
Full Name | Apolipoprotein E |
---|---|
Synonym | Apo-E;MGC1571;apolipoprotein E3; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 23.44-1500ng/mL |
Sensitivity | 14.07ng/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human ApoE in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ApoE. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ApoE and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ApoE, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ApoE. You can calculate the concentration of Human ApoE in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human ApoE ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 74.1 | 159.2 | 668.38 | 78.65 | 161.5 | 660.91 |
Standard deviation | 4.28 | 8.76 | 34.69 | 4.68 | 9.3 | 26.97 |
CV(%) | 5.78 | 5.5 | 5.19 | 5.95 | 5.76 | 4.08 |
RECOVERY
The recovery of Human ApoE spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 87-102 | 93 |
EDTA plasma (n=8) | 94-108 | 102 |
Cell culture media (n=8) | 88-104 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human ApoE in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with APOE ELISA Kits
APOB ELISA Kit | publications with APOE and APOB |
LDLR ELISA Kit | publications with APOE and LDLR |
LPL ELISA Kit | publications with APOE and LPL |
APOA1 ELISA Kit | publications with APOE and APOA1 |
LRP1 ELISA Kit | publications with APOE and LRP1 |
APOC3 ELISA Kit | publications with APOE and APOC3 |
APOA2 ELISA Kit | publications with APOE and APOA2 |
LRP8 ELISA Kit | publications with APOE and LRP8 |
HSPG2 ELISA Kit | publications with APOE and HSPG2 |
LRP2 ELISA Kit | publications with APOE and LRP2 |
Pathways associated with APOE ELISA Kit
Alzheimer's Disease Pathway | Alzheimer's Disease Pathway |
Alzheimers Disease Pathway | Alzheimers Disease Pathway |
Binding And Uptake Of Ligands By Scavenger Receptors Pathway | Binding And Uptake Of Ligands By Scavenger Receptors Pathway |
Chylomicron-mediated Lipid Transport Pathway | Chylomicron-mediated Lipid Transport Pathway |
HDL-mediated Lipid Transport Pathway | HDL-mediated Lipid Transport Pathway |
Lipid Digestion, Mobilization, And Transport Pathway | Lipid Digestion, Mobilization, And Transport Pathway |
Lipoprotein Metabolism Pathway | Lipoprotein Metabolism Pathway |
Metabolism Pathway | Metabolism Pathway |
Metabolism Of Fat-soluble Vitamins Pathway | Metabolism Of Fat-soluble Vitamins Pathway |
Diseases associated with APOE ELISA Kit
Cardiovascular Diseases | publications with APOE and Cardiovascular Diseases |
Alzheimer Disease | publications with APOE and Alzheimer Disease |
Atherosclerosis | publications with APOE and Atherosclerosis |
Arteriosclerosis | publications with APOE and Arteriosclerosis |
Dyslipidemias | publications with APOE and Dyslipidemias |
Inflammation | publications with APOE and Inflammation |
Hyperlipidemias | publications with APOE and Hyperlipidemias |
Cognition Disorders | publications with APOE and Cognition Disorders |
Plaque, Atherosclerotic | publications with APOE and Plaque, Atherosclerotic |
Coronary Disease | publications with APOE and Coronary Disease |
Organs/Tissues associated with APOE ELISA Kit
Brain | publications with APOE and Brain |
Vascular | publications with APOE and Vascular |
Liver | publications with APOE and Liver |
Heart | publications with APOE and Heart |
Muscle | publications with APOE and Muscle |
Nerve | publications with APOE and Nerve |
Bone | publications with APOE and Bone |
Kidney | publications with APOE and Kidney |
Lung | publications with APOE and Lung |
Spleen | publications with APOE and Spleen |